Cargando…

Drug-resistant tuberculosis control in China: progress and challenges

BACKGROUND: China has the second highest caseload of multidrug-resistant tuberculosis (MDR-TB) in the world. In 2009, the Chinese government agreed to draw up a plan for MDR-TB prevention and control in the context of a comprehensive health system reform launched in the same year. DISCUSSION: China...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Qian, Qu, Yan, Lucas, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731907/ https://www.ncbi.nlm.nih.gov/pubmed/26822738 http://dx.doi.org/10.1186/s40249-016-0103-3

Ejemplares similares

Multi-source financing for tuberculosis treatment in China: key issues and challenges
por: Long, Qian, et al.
Publicado: (2021)

Brucellosis in China: history, progress and challenge
por: Jiang, Hai, et al.
Publicado: (2020)

Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis
por: Laniado-Laborín, Rafael
Publicado: (2017)

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy
por: Trauner, Andrej, et al.
Publicado: (2014)

China’s biggest, most neglected health challenge: Non-communicable diseases
por: Tang, Shenglan, et al.
Publicado: (2013)

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
por: Gupta, Aastha, et al.
Publicado: (2022)

Tuberculosis Progression Does Not Necessarily Equate with a Failure of Immune Control
por: Russell, David G.
Publicado: (2019)

Global immunization: status, progress, challenges and future
por: Philippe, Duclos, et al.
Publicado: (2009)

Challenges in Drug Discovery for Intracellular Bacteria
por: Tucker, Allison N., et al.
Publicado: (2021)

Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China
por: Li, Xiao-Qiao, et al.
Publicado: (2018)

Challenges to replace ACT as first-line drug
por: Phyo, Aung Pyae, et al.
Publicado: (2017)

Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
por: Wu, Tong, et al.
Publicado: (2022)

Time to tackle clonorchiasis in China
por: Qian, Men-Bao, et al.
Publicado: (2013)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
por: Stephanie, Filia, et al.
Publicado: (2021)

Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
por: Gandalovičová, Aneta, et al.
Publicado: (2017)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

Achieving development goals for HIV, tuberculosis and malaria in sub-Saharan Africa through integrated antenatal care: barriers and challenges
por: Fowkes, Freya J. I., et al.
Publicado: (2016)

The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building
por: Liu, Yu-Hong, et al.
Publicado: (2020)

The MyToolbox EU–China Partnership—Progress and Future Directions in Mycotoxin Research and Management
por: Leslie, John, et al.
Publicado: (2020)

Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic
por: Perez Perez, Guillermo I., et al.
Publicado: (2020)

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
por: Dunlop, Adrian, et al.
Publicado: (2020)

Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria
por: Bassat, Quique, et al.
Publicado: (2022)

Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective
Publicado: (2015)

microRNAs: a role in drug resistance in parasitic nematodes?
por: Devaney, Eileen, et al.
Publicado: (2010)

Tuberculosis infection prevention and control: why we need a whole systems approach
por: Kielmann, Karina, et al.
Publicado: (2020)

Schistosomiasis control and the health system in P.R. China
por: Collins, Charles, et al.
Publicado: (2012)

Photobactericides—A Local Option against Multi-Drug Resistant Bacteria
por: Wainwright, Mark, et al.
Publicado: (2013)

Mitochondria in colorectal cancer stem cells - a target in drug resistance
por: Rainho, Mateus de Almeida, et al.
Publicado: (2023)

Transfusion-Acquired HIV: History, Evolution of Screening Tests, and Current Challenges of Unreported Antiretroviral Drug Use in Brazil
por: Nishiya, Anna S., et al.
Publicado: (2022)

Summary of the Current Status of African Swine Fever Vaccine Development in China
por: Han, Naijun, et al.
Publicado: (2023)

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government
por: van der Pol, Karel H., et al.
Publicado: (2023)

Continuing progress toward controlled intracellular delivery of semiconductor quantum dots
por: Breger, Joyce, et al.
Publicado: (2015)

What Do We Really Know about How CD4 T Cells Control Mycobacterium tuberculosis?
por: Torrado, Egidio, et al.
Publicado: (2011)

Treating Leaky Syndrome in the Over 65s: Progress and Challenges
por: Jain, Shalini, et al.
Publicado: (2023)

Combating echinococcosis in China: strengthening the research and development
por: Qian, Men-Bao, et al.
Publicado: (2017)

Remote Prescription During Pandemic: Challenges and Solutions
por: Lim, Ee-Chien, et al.
Publicado: (2021)

Poverty and malaria in the Yunnan province, China
por: Bi, Yan, et al.
Publicado: (2014)

How Compounding Pharmacies Fill Critical Gaps in Pediatric Drug Development Processes: Suggested Regulatory Changes to Meet Future Challenges
por: MacArthur, Robert B., et al.
Publicado: (2022)

National Natural Science Foundation of China leads the comprehensive development of basic research in the field of male reproductive health in China
por: Liao, Shu-Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j1tgoq07skr8qe8ireq8fb5dph